Ourania Tsitsilonis
Visiting Professor, Tumor Immunology
22713000
School of Sciences
Visiting Professor
Qualification | Year | Awarding Institution | Department | Thesis title |
PhD Immunology | 1993 | NKUA | Biology | Contribution to the study of prothymosin α and parathymosin α in man |
BSc in Medicine | 1995 | NKUA | Medicine | |
BSc in Biology | 1986 | NKUA | Biology |
Period of employment | Employer | Location | Position | |
From | To | |||
1994 | 1996 | University of Tuebingen | Germany | Post-doctoral fellow |
1996 | 2002 | St. Savas Cancer Hospital | Athens | Resident and Senior investigator |
2002 | present | NKUA | Athens | Faculty member |
Year | Title | Other authors | Journal and Publisher / Conference | Vol. | Pages |
2018 | Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis | Kastritis E, Kostopoulos IV, Terpos E, Paiva B, Fotiou D, Gavriatopoulou M, Kanellias N, Ziogas DC, Roussou M, Migkou M, Eleutherakis-Papaiakovou E, Trougakos IP, Dimopoulos MA. | Blood Cancer J. | 8 | 46 |
2018 | Molecular responses to therapeutic proteasome inhibitors in multiple myeloma patients are donor-, cell type- and drug-dependent | Papanagnou ED, Terpos E, Kastritis E, Papassideri IS, Dimopoulos MA, Trougakos IP. | Oncotarget | 9 | 17797 |
2018 | Selective cytotoxicity of the herbal substance acteoside against tumor cells and its mechanistic insights | Cheimonidi C, Samara P, Polychronopoulos P, Tsakiri EN, Nikou T, Myria-nthopoulos V, Sakellaro-poulos T, Zoumpourlis V, Mikros E, Papassideri I, Argyropoulou A, Halabalaki M, Alexopoulos LG, Skaltsounis AL, Aligiannis NN, Trougakos IP. | Redox Biol. | 16 | 169 |
2017 | Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis | Kostopoulos IV, Paterakis G, Pavlidis D, Kastritis E, Terpos E, Papadhimitriou SI. | Blood Cancer J. | 7 | 597 |
2017 | Frequencies of peripheral immune cells in older adults following seasonal influenza vaccination with an adjuvanted vaccine. | Goldeck D, Theeten H, Hassouneh F, Oettinger L, Wistuba-Hamprecht K, Cools N, Pawelec G. | Vaccine | 35 | 4330 |
2017 | A fragment of the alarmin prothymosin α as a novel biomarker in murine models of bacteria-induced sepsis. | Samara P, Miriagou V, Zachariadis M, Mavrofrydi O, Promponas VJ, Dedos SG, Papazafiri P, Kalbacher H, Voelter W. | Oncotarget | 8 | 48635 |
2017 | New semi-synthetic analogs of oleuropein show improved anticancer activity in vitro and in vivo. | Samara P, Christoforidou N, Lemus C, Argyropoulou A, Ioannou K, Vougogia-nnopoulou K, Aligiannis N, Paronis E, Gaboriaud-Kolar N, Skaltsounis AL. | Eur. J. Med. Chem. | 137 | 11 |
2017 | In vivo biodistribution and imaging studies with a 99mTc-radiolabeled derivative of the C-terminus of prothymosin alpha in mice bearing experimentally-induced inflammation. | Karachaliou CE, Triantis C, Liolios C, Palamaris L, Zikos C, Kalbacher H, Voelter W, Loudos G, Papadopoulos M, Pirmettis I, Livaniou E. | Eur. J. Pharm. Biopharm. | 113 | 188 |
2016 | Harnessing the immune system to improve cancer therapy. | Papaioannou NE, Beniata OV, Vitsos P, Samara P. | Ann. Transl. Med. | 4 | 261 |
2014 | ISO-66, a novel inhibitor of macrophage migration, shows efficacy in melanoma and colon cancer models. | Ioannou K, Cheng KF, Crichlow GV, Birmpilis AI, Lolis EJ, Al-Abed Y. | Int. J. Oncol. | 454 | 1457 |
Date | Title | Funded by | Project Role* |
2018 | Novel Biomarkers and Potential Therapeutic Targets for the Management of Patients with Multiple Myeloma | GSRT | Contact person |
2017 | Detection and quantitation of MRD in patients with Multiple Myeloma | National Organisation for Healthcare Provision | Coordinator |
2018 | Prognostic value of MRD in hematopoietic stem cell products of patients with Multiple Myeloma subjected to ASCT | HESMO | Co-coordinator |
2017 | Cellular, signalling and metabolic changes during infection with HCV | ELIDEK | Coordinator |
2017 | Development, evaluation and clinical application of a new method for the detection of MRD in patients with Multiple Myeloma using next-generation flow cytometry | IKY | Coordinator |
2014-2016 | Study on the mode of action of prothymosin alpha, aiming at clinical exploitation of its decapeptide fragment | IKY | Coordinator |
2013-2015 | Immune signatures within the tumor and in the peripheral blood as prognostic/predictive biomarkers in breast cancer | GSRT | Co-coordinator |
2011-2014 | Integrating the emerging research potential of the University of Athens cancer Research group in the European research area | FP7-REGPOT-2011 | Member |
2013 | Development of ELISA for quantitating the novel infection marker prothymosin alpha (100-109) in blood plasma | Latsis Foundation | Coordinator |
2008-2011 | Development of a novel immunoassay for the very early detection of biothreatening bacterial infections | ΝΑΤΟ SfP 982838 | Co-coordinator |
Period | Organization | Title of Position or Service | Key Activities |
2016-now | BMS | Advisor | Presentations/review of new cancer immunotherapeutic protocols |
2016-now | Hellenic Society of Immuno-Oncology | General Secretary | Advisor/congress organizer/public and patient update |
2015-now | NKUA, Department of Biology | Vice President | Undergraduate, postgraduate, doctorate programmes, students’ internship, students’ transfer, etc |
2004-now | GSRT, IKY, MOH-Greece, University of Antwerp, Bulgarian Academy of Science, DFG | Reviewer | Evaluator of proposals |
2000-now | Various international journals | Reviewer | Manuscript review |
Date | Title | Awarded by: |
2018 | 1st award for best presentation | Hellenic Society of Vascular Surgery |
2017 | 2nd award for best presentation | Hellenic Society of Immuno-oncology |
2017 | “Stem cell” award | 43rd Panhellenic Medical Congress |
2014 | Honorary award for best basic research presentation | 40th Panhellenic Medical Congress |
2011 | Honorary award for best basic research presentation | 37th Panhellenic Medical Congress |
2004 | Research award | Empeirikion Foundation |
2005-now | Invited educational seminars for secondary school students and instructors | Ministry of Education |
1998-now | Invited plenary lectures in National and International Conferences, Seminars, Workshops, Meetings | Various medical societies |
Date | Title | Key Activities: |
2002-now | 12 PhD Theses (7 completed) | PhD Theses supervisor |
2002-now | 41 MSc Theses (39 completed) | MSc Theses supervisor |
2002-now | 82 undergraduate Theses (76 completed) | Undergraduate Theses supervisor |
2002-now | Participation in 7 MSc programmes | Lectures and practicals |
2012 | Short-term visiting professor | Participated in organization of lectures and practicals of the course “Immunology” at the University of Cyprus |
1986-now | Research impact | 77 original publications at peer-reviewed international journals (total impact factor 243) |
1986-now | Research impact | > 1600 citations; h-index 23 |
2003-now | Textbooks | Participated in translation teams of 5 books |
2017-now | ISO 9001:2015 | Accreditation of Flow Cytometry Unit of NKUA |
2006-now | Congress organization | Member of organizing committee of 12 Congresses |